InvestorsHub Logo
Followers 30
Posts 2784
Boards Moderated 0
Alias Born 09/14/2012

Re: andy55q post# 4773

Friday, 01/24/2014 11:27:25 PM

Friday, January 24, 2014 11:27:25 PM

Post# of 18434
Isn't anyone else confused about these articles. We have known that Aethlon can detect different types of cancer exosomes using their EllSA test for over a year, so why is MD Anderson getting the PR credit for a simple blood tests for cancer exosomes? It's not new news, just a larger company. IMO, there is no way MD Anderson is allowing this unless they have connections with Aethlon. Maybe they are using Aethlon's ELLSA test for their research. How do you think Aethlon found different types of cancer exosomes, but by sampling blood, but yet the PR is flying off of just one MD Anderson PR. Please educate me on this issue.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News